BioSpace News Archive

The I-SPY COVID Trial, sponsored by Quantum Leap Healthcare Collaborative (QLHC), was designed to rapidly screen agents that show promise for reducing the time to recovery (defined as reduction in oxygen demand) by approximately 50% or risk of mortality in critically ill COVID-19 patients.

Vitruvian Partners, one of the world’s leading growth-focused investment firms, announced that it has acquired a majority ownership stake in KCAS Bioanalytical and Biomarker Services (KCAS), located in the Kansas City, Kansas metropolitan area.

The World Stroke Organization is calling for increased awareness of the symptoms of a rare type of stroke that has been linked to a Johnson & Johnson and AstraZeneca COVID-19 vaccines

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced that the company plans to issue a pre-market press release and conduct a webcast on Friday, April 16, 2021, to discuss clinical data from the ongoing Phase 1/2 trial evaluating darovasertib

Lexaria Bioscience Corp., a global innovator in drug delivery platforms, announces the appointment of a new Chief Financial Officer and the issuance of share purchase warrants to third party consultants.

Veracyte, Inc . (Nasdaq: VCYT) announced that Keith Kennedy, chief financial officer and chief operating officer, will retire from the company, effective May 15, 2021, following the company’s release of its full quarterly financial results

Development of new-generation drug-eluting balloon catheters has been gaining pace, thanks to increasing research and development initiatives

A wide range of tests finds clinical application in blood group typing—there are as many as 33 blood group systems. Quite wide array of techniques and instruments have become popular in cross-matching tests in transfusion medicine.

Health Gorilla, a leader in clinical data APIs, and Triple-S, an independent licensee of the Blue Cross Blue Shield Association and the largest health insurance company in Puerto Rico, today announced a strategic collaboration to achieve bi-directional access to clinical data to improve quality, reduce costs, and improve the member experience.

Proxima Clinical Research (“Proxima CRO”), a contract research organization (CRO) based out of the Texas Medical Center in Houston, announced today it has experienced tremendous growth in clients, clinical studies, and new hires in the last half of CY 2020 and first quarter of CY 2021.